🏛️ Verified NIH Record • Updated 2026-02-19
XIENCE Skypoint Large Vessel Post Approval Study (NCT05423379)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Abbott Medical Devices
🩺 Plain-English Summary (8th-Grade Level)
SPIRIT XLV PAS is a prospective, single arm, multi-center, US and OUS post-approval observational study to evaluate the continued safety and effectiveness of the XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS) Large Vessel (LV) sizes (diameter 4.5 mm and 5.0 mm) during commercial use in a real-world setting.
Who can join: Review the eligibility criteria below.
Location: Arkansas Heart Hospital — Little Rock, Arkansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Arkansas Heart Hospital — Little Rock, Arkansas
- Memorial Hospital Jacksonville — Jacksonville, Florida
- Tallahassee Research Institute — Tallahassee, Florida
- Via Christi Regional Medical Center - St. Francis Campus — Wichita, Kansas
- Bryan Heart — Lincoln, Nebraska
- Lenox Hill Hospital — New York, New York
- Pinnacle Health System — Wormleysburg, Pennsylvania
- Anmed Health — Anderson, South Carolina
- Greenville Health System — Greenville, South Carolina
- Hendrick Medical Center — Abilene, Texas
- Austin Heart — Austin, Texas
- The Heart Hospital Baylor Plano — Plano, Texas
- Shannon Clinic — San Angelo, Texas
- Clinique Pasteur Toulouse — Toulouse, Midi-Pyrenees
- Hopital Cardiovasculaire et Pneumologique Louis Pradel — Lyon, Rhone
- Hospital Clinico San Carlos — Madrid, Madrid
- Hospital Universitario Marqués de Valdecilla — Santander,
- Hospital Virgen de Rocio — Seville,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease
- Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended — Stanford, California
- Genomic Investigation of Cardiovascular Diseases — La Jolla, California
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health — Boston, Massachusetts
- A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD — Mobile, Alabama
- Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Birmingham, Alabama
- Precision PCI Registry — Gainesville, Florida
Explore by condition: All Coronary Artery Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.